All Rights Reserved | EUROGENETIC
EUROGENETIC
Vascular cardiology is the branch of medicine that deals with the study and treatment of diseases and disorders that affect the heart and vascular system. Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in Western countries.
Some risk factors are high cholesterol, high blood pressure, diabetes, smoking, and obesity. Genetics play a key role in the diagnosis and prevention of cardiovascular disease: early detection and timely diagnosis of heart disease can lead to better treatment options, help prevent sudden cardiac death, and improve prognosis.
NON-INVASIVE GENETIC TEST for the analysis of polymorphisms associated with an increased risk of cardiovascular disease, with the aim of determining individual risk profiles aimed at personalized treatment and early prevention of these diseases.
The onset of cardiovascular diseases is induced by several factors such as diet and lifestyle and genetics which plays a very important role.
Knowing the genetic predispositions for the development of these pathologies allows us to undertake preventive and corrective measures in order to anticipate and in some cases avoid the pathological manifestation.
The test is based on the analysis using the Next Generation Sequencing (NGS) technique of 50 genetic polymorphisms, located in 38 genes.
OUR TESTS
SUDDEN CARDIAC ARREST TEST
Sudden Cardiac Arrest Prevention® is a diagnostic test that allows for multiple genetic analysis to evaluate the presence of mutations associated with sudden cardiac death sine materia. The test allows for the identification of patients at genetic risk of potentially fatal cardiac events, through the analysis of their DNA.
GENES/POLYMORPHISMS INVESTIGATED
ABCC9, ABCG5, ABCG8, ACTA1, ACTA2, ACTC1, ACTN2, AKAP9, ALMS1, ANK2, ANKRD1, APOA5, APOB, APOC2, APOE, BAG3, BRAF, CACNA1C, CACNB2, CALM1, CALR3, CASQ2, CAV3, CBL, CBS, CETP, COL3A1, COL5A1, COL5A2, COX15, CRELD1, CRYAB, CSRP3, CTF1, DES, DMD, DNAJC19, DOLK, DPP6, DSC2, DSG2, DSP, DTNA, EFEMP2, ELN, EMD, EYA4, FBN1, FBN2, FHL1, FHL2, FKRP, FKTN, FXN, GAA, GATAD1, GCKR, GJA5, GLA, GNAS, GPD1L, GPIHBP1, HADHA, HCN4, HFE, HRAS, HSPB8, JAG1, JPH2, JUP, KCNA5, KCND3, KCNE1, KCNE2, KCNE3, KCNH2, KCNJ2, KCNJ5, KCNQ1, KRAS, LAMA2, LAMA4, LAMP2, LDB3, LDLR, LDLRAP1, LMF1, LMNA, LPL, LTBP2, MAP2K1, MAP2K2, MIB1, MYBPC3, MYH11, MYH6, MYH7, MYL2, MYL3, MYLK, MYLK2, MYO6, MYOZ2, MYPN, NEXN, NKX2-5, NODAL, NOTCH1, NPPA, NRAS, PCSK9, PKP2, PLN, PRDM16, PRKAG2, PRKAR1A, PTPN11, RAF1, RBM20, RYR1, RYR2, SALL4, SCN1B, SCN2B, SCN3B, SCN4B, SCN5A, SCO2, SDHA, SEPN1, SGCB, SGCD, SGCG, SHOC2, SLC25A4, SLC2A10, SMAD3, SMAD4, SNTA1, SOS1, TAZ, TBX20, TBX3, TBX5, TCAP, TGFB2, TGFB3, TGFBR1, TGFBR2, TMEM43, TMPO, TNNC1, TNNI3, TNNT2, TPM1, TRDN, TRPM4, TTN, TTR, VCL, ZIC3
HERITAGE CARDIOMYOPATHY TEST
Cardiomyopathies® is a diagnostic test that allows for a multiple genetic analysis to evaluate the presence of mutations associated with hereditary cardiomyopathies.
The test allows to identify patients at genetic risk of potentially fatal cardiac events, through the analysis of their DNA.
GENES/POLYMORPHISMS INVESTIGATED
ABCC9, ACTC1, ACTN2, ANKRD1, CASQ2, CAV3, CRYAB, CSRP3, CTF1, DES, DSC2, DSG2, DSP, DTNA, EMD, FHL2, GLA, JUP, LAMA4, LAMP2, LDB3, LMNA, MYBPC3, MYH6, MYH7, MYL2, MYL3, MYLK2, MYOZ2, NEXN, PKP2, PLN, PRKAG2, RBM20, RYR2, SGCD, TAZ, TCAP, TMEM43, TNNC1, TNNI3, TNNT2, TPM1, TTN, TTR, VCL
FAMILIAL DILATED CARDIOMYOPATHY TEST
GENES/POLYMORPHISMS INVESTIGATED
ABCC9, ACTC1, ACTN2, ANKRD1, BAG3, CRYAB, CSRP3, DES, DMD, DNAJC19, DOLK, DSC2, DSG2, DSP, EMD, EYA4, FKTN, GATA4, GATAD1, ILK, LAMA4, LAMP2, LDB3, LMNA, MURC, MYBPC3, MYH6, MYH7, MYPN, NEBL, NEXN, PDLIM3, PKP2, PLN, RAF1, RBM20, SCN5A, SGCD, TAZ, TBX20, TCAP, TNNC1, TNNI3, TNNT2, TPM1, TTN, TTR, TXNRD2, VCL